JUVE Fundamental Analysis - JUVENTUS FOOTBALL CLUB SPA

Fundamental Rating

Taking everything into account, JUVE scores 1 out of 10 in our fundamental rating. JUVE was compared to 44 industry peers in the Entertainment industry. JUVE may be in some trouble as it scores bad on both profitability and health. JUVE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

JUVE had negative earnings in the past year.

JUVE had a positive operating cash flow in the past year.

In the past 5 years JUVE always reported negative net income.

In multiple years JUVE reported negative operating cash flow during the last 5 years.

1.2 Ratios

JUVE's Return On Assets of -7.34% is on the low side compared to the rest of the industry. JUVE is outperformed by 65.91% of its industry peers.

JUVE has a worse Return On Equity (-439.14%) than 75.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROIC	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

JUVE has a better Gross Margin (88.51%) than 72.73% of its industry peers.

JUVE's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for JUVE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	88.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, JUVE has about the same amount of shares outstanding.

The number of shares outstanding for JUVE has been reduced compared to 5 years ago.

The debt/assets ratio for JUVE is higher compared to a year ago.

2.2 Solvency

JUVE has an Altman-Z score of 0.47. This is a bad value and indicates that JUVE is not financially healthy and even has some risk of bankruptcy.

JUVE's Altman-Z score of 0.47 is in line compared to the rest of the industry. JUVE outperforms 40.91% of its industry peers.

A Debt/Equity ratio of 21.46 is on the high side and indicates that JUVE has dependencies on debt financing.

JUVE has a worse Debt to Equity ratio (21.46) than 75.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Altman-Z	0.47

ROIC/WACCN/A

WACC7.17%

2.3 Liquidity

JUVE has a Current Ratio of 0.47. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.

JUVE's Current ratio of 0.47 is on the low side compared to the rest of the industry. JUVE is outperformed by 84.09% of its industry peers.

A Quick Ratio of 0.47 indicates that JUVE may have some problems paying its short term obligations.

With a Quick ratio value of 0.47, JUVE is not doing good in the industry: 84.09% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.47
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.82% over the past year.

The Revenue has grown by 18.31% in the past year. This is quite good.

The Revenue has been growing slightly by 1.84% on average over the past years.

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

3.2 Future

The Earnings Per Share is expected to decrease by -17.73% on average over the next years. This is quite bad

JUVE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.36% yearly.

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.73%

EPS Next 5YN/A

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.37%

Revenue Next 5Y2.36%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUVE. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JUVE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JUVE.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	34.96

4.3 Compensation for Growth

A cheap valuation may be justified as JUVE's earnings are expected to decrease with -17.73% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.46%

EPS Next 3Y-17.73%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for JUVE!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (11/28/2025, 7:00:00 PM)

2.32

-0.02 (-1.02%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)09-26 2025-09-26/amc

Earnings (Next)02-26 2026-02-26

Inst Owners11.12%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap879.56M

Revenue(TTM)439.76M

Net Income(TTM)-58.15M

Analysts41.82

Price Target2.69 (15.95%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-12.71%

PT rev (3m)-11.24%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-260%

EPS NY rev (3m)-203.34%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.51%

Revenue NY rev (3m)-5.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2
P/FCF	N/A
P/OCF	34.25
P/B	66.43
P/tB	N/A
EV/EBITDA	34.96

EPS(TTM)-0.21

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.52

FCFYN/A

OCF(TTM)0.07

OCFY2.92%

SpS1.16

BVpS0.03

TBVpS-0.97

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	88.51%
FCFM	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

F-Score6

Asset Turnover0.56

Health

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Debt/EBITDA	8.67
Cap/Depr	162.73%
Cap/Sales	50.75%
Interest Coverage	N/A
Cash Conversion	78.39%
Profit Quality	N/A
Current Ratio	0.47
Quick Ratio	0.47
Altman-Z	0.47

F-Score6

WACC7.17%

ROIC/WACCN/A

Cap/Depr(3y)108.07%

Cap/Depr(5y)101.17%

Cap/Sales(3y)37.97%

Cap/Sales(5y)38.64%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.73%

EPS Next 5YN/A

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.37%

Revenue Next 5Y2.36%

EBIT growth 1Y42.21%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year6654%

EBIT Next 3Y290.51%

EBIT Next 5Y135.22%

FCF growth 1Y-31.13%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y155.76%

OCF growth 3YN/A

OCF growth 5YN/A

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to JUVE.MI.

Can you provide the valuation status for JUVENTUS FOOTBALL CLUB SPA?

ChartMill assigns a valuation rating of 0 / 10 to JUVENTUS FOOTBALL CLUB SPA (JUVE.MI). This can be considered as Overvalued.

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) has a profitability rating of 1 / 10.

How financially healthy is JUVENTUS FOOTBALL CLUB SPA?

The financial health rating of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) is 1 / 10.

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

Can you provide the valuation status for JUVENTUS FOOTBALL CLUB SPA?

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

How financially healthy is JUVENTUS FOOTBALL CLUB SPA?